Kiniksa Pharmaceuticals International plc (KNSA), which reported second-quarter results last week, is one of the top gainers in premarket trading today. The company demonstrated robust commercial performance, driven by expanding penetration of its flagship product, Arcalyst, in the recurrent pericarditis population, supported by growth among both new and repeat prescribers.
The following is the list of biotech stocks making big moves in premarket hours.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com